Pharmacy repackaging systems market seen reaching $3.69 billion by 2030

The pharmacy repackaging systems market is projected to grow from $2.36 billion in 2025 to $3.69 billion by 2030, according to a new market outlook from The Business Research Company. The forecast points to rising demand for automation, medication safety and traceability as chronic disease cases and prescription volumes climb.

Why it matters: - Pharmacy repackaging systems help pharmacies move medications from bulk containers into patient-specific packaging. - The systems are designed to improve dosing accuracy, medication adherence and safety. - The market’s growth reflects broader pressure on healthcare providers to reduce errors and handle higher medication volumes.

What happened: - The Business Research Company projected the global pharmacy repackaging systems market will rise from $2.36 billion in 2025 to $2.59 billion in 2026. - The firm said the market will reach $3.69 billion by 2030. - The forecast implies a 9.3% compound annual growth rate through the period. - The report was released Aug. 24, 2026, from London. - The company also offered a free sample of the report and the full market report.

The details: - Growth through 2026 is linked to hospital pharmacy automation, medication-error reduction efforts, expansion of long-term care pharmacies, higher prescription volumes and packaging technology improvements. - Growth through 2030 is expected to be supported by intelligent pharmacy systems, stronger traceability and compliance requirements, mail-order pharmacy growth, demand for high-throughput repackaging and more automation investment. - Key trends include automated unit dose packaging, blister and pouch packaging automation, barcode and tracking technology integration, high-speed repackaging and a stronger focus on medication precision. - Chronic disease prevalence is a major driver because more patients need ongoing medication management. - The report defines chronic diseases as long-term conditions that last a year or more and often require continuous medical attention. - The report links the rise in chronic disease to aging populations, unhealthy diets, reduced physical activity, urbanization and environmental factors. - The UK National Health Service reported in June 2024 that 3,615,330 people registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023. - That figure was up 18% from 3,065,825 cases in 2022. - The report said North America held the largest market share in 2025. - The Asia-Pacific region is projected to be the fastest-growing regional market. - Other regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests pharmacy operations are moving from manual workflow support toward more automated, traceable and high-throughput systems. - The emphasis on safety, compliance and barcode tracking shows that regulation and error reduction are becoming as important as speed. - Rising chronic disease counts add a long-term demand tail because more patients need organized, repeat medication dispensing.

What's next: - Market demand is likely to track continued automation spending in hospitals, long-term care and mail-order pharmacy operations. - Regional growth may widen as Asia-Pacific scales pharmacy infrastructure and packaging automation. - The report’s added analytics, including TAM analysis, company scoring and forecasting dashboards, indicate a stronger focus on competitive positioning and investment planning.